Scolaris Content Display Scolaris Content Display

Terapias psicológicas para el tratamiento del dolor crónico y recurrente en niños y adolescentes

Appendices

Appendix 1. Previous search results

Four separate searches were undertaken. The first search was undertaken from inception of the abstracting services to the end of 1999 (Eccleston 2003). This yielded 3715 abstracts, of which 123 were read in full, identifying 18 RCTs.

The second search, which updated the original review, was undertaken focusing on the 10 years since the previous search, overlapping by one year (from 1999 to 2008) and was later published (Eccleston 2009). This yielded 1319 abstracts, of which 45 papers were read in full, identifying a further 16 RCTs, giving a total set of 34. However, five studies were later excluded because they did not meet the minimum criteria of 10 participants in each arm, therefore, leaving 29 studies.

The third search, which searched databases from 2008 to March 2012, yielded 851 abstracts, of which 25 papers were read in full, and eight further RCTs were included in the review (Eccleston 2012).

The fourth search, which searched databases from March 2012 to January 2014, yielded 443 abstracts, of which 19 were read in full, and seven papers were included (Grob 2013; Gulewitsch 2013; Hechler 2014; Kashikar‐Zuck 2012; Levy 2010; Powers 2013; Van der Veek 2013). Kashikar‐Zuck 2012 and Levy 2010 provided additional data for studies previously included in this review. Five studies that were previously included, were excluded from this review since treatment was delivered remotely (Connelly 2006; Hicks 2006; Palermo 2009; Stinson 2010; Trautmann 2010). Therefore, a total of 37 RCTs were included (39 papers; Eccleston 2014).

Appendix 2. Model over‐fitting

We used AIC to mitigate the risk of overfitting due to repeated sensitivity analyses. The AIC scores indicate that all meta‐analyses are more parsimonious than meta‐regressions/subgroup analyses except pain intensity in children with mixed pain conditions at post‐treatment. Here, sample size explained enough variation to be worth including in the model based on change in AIC score. The model had very high inconsistency, partly explained by publication bias, but there was further heterogeneity not explained by our subgroup and sensitivity analyses. This reduced our confidence in the estimate of effect which is reflected in the GRADE assessment and 'summary of findings' tables.

Appendix 3. 2017 Search strategies

CENTRAL (CRSO)

#1 MeSH descriptor: [Child] explode all trees
#2 MeSH descriptor: [Infant] explode all trees
#3 MeSH descriptor: [Adolescent] explode all trees
#4 (child* or adolescent* or infant*or juvenil* or pediatric* or paediatric* or "young person*" or "young people" or youth* or "young adult*"):it,ab,kw (Word variations have been searched)
#5 #1 or #2 or #3 or #4
#6 MeSH descriptor: [Psychology] explode all trees
#7 MeSH descriptor: [Psychotherapy] explode all trees
#8 MeSH descriptor: [Behavior Therapy] explode all trees
#9 (psycholog* or (behavio?r and therapy) or hypnos* or relaxation* or ((family or color or colour or music or play) next therap*) or imagery or cogniti* or psychotherap*):it,ab,kw (Word variations have been searched)
#10 #6 or #7 or #8 or #9
#11 (pain* or headache* or "head ache*" or head‐ache* or migraine* or cephalalgi* or "stomach ache*" or "tummy ache*" or "abdominal ache*" or "belly ache*" or earache* or ear‐ache* or toothache* or tooth‐ache* or odontalgi* or dysmenorrh* or neuralgi*):it,ab,kw (Word variations have been searched)
#12 MeSH descriptor: [Pain] explode all trees
#13 MeSH descriptor: [Headache Disorders] explode all trees
#14 #11 or #12 or #13
#15 #5 and #10 and #14

MEDLINE via Ovid search strategy

1. exp child/

2. Infant/

3. Adolescent/

4. (child$ or adolescent$ or infant$ or juvenil$ or pediatric$ or paediatric$ or "young person$" or "young people" or youth$ or "young adult$").ab,it,kf.

5. 1 or 2 or 3 or 4

6. exp Psychology/

7. exp Psychotherapy/

8. exp Behavior Therapy/

9. (psycholog$ or (behavio?r and therapy) or hypnos$ or relaxation$ or ((family or color or colour or music or play) adj therap$) or imagery or cogniti$ or psychotherap$).ab,it,kf.

10. 6 or 7 or 8 or 9

11. (pain$ or headache$ or "head ache$" or head‐ache$ or migraine$ or cephalalgi$ or "stomach ache$" or "tummy ache$" or "abdominal ache$" or "belly ache$" or earache$ or ear‐ache$ or toothache$ or tooth‐ache$ or odontalgi$ or dysmenorrh$ or neuralgi$).ab,it,kf.

12. exp Pain/

13. exp Headache Disorders/

14. 11 or 12 or 13

15. 5 and 10 and 14

16 randomized controlled trial.pt.

17 controlled clinical trial.pt.

18 randomized.ab.

19 placebo.ab.

20 drug therapy.fs.

21 randomly.ab.

22 trial.ab.

23 or/16‐22

24 exp animals/ not humans.sh.

25 23 not 24

26 25 and 15

Embase via Ovid search strategy

1. Child/

2. Infant/

3. Adolescent/

4. (child$ or adolescent$ or infant$ or juvenil$ or pediatric$ or paediatric$ or "young person$" or "young people" or youth$ or "young adult$").ab,it.

5. 1 or 2 or 3 or 4

6. exp PSYCHOLOGY/

7. exp PSYCHOTHERAPY/

8. behavior therapy/

9. (psycholog$ or (behavio?r and therapy) or hypnos$ or relaxation$ or ((family or color or colour or music or play) adj therap$) or imagery or cogniti$ or psychotherap$).ab,it.

10. 6 or 7 or 8 or 9

11. (pain$ or headache$ or "head ache$" or head‐ache$ or migraine$ or cephalalgi$ or "stomach ache$" or "tummy ache$" or "abdominal ache$" or "belly ache$" or earache$ or ear‐ache$ or toothache$ or tooth‐ache$ or odontalgi$ or dysmenorrh$ or neuralgi$).ab,it.

12. exp Pain/

13. exp "Headache and Facial Pain"/

14. 11 or 12 or 13

15. 5 and 10 and 14

16 random$.tw.

17 factorial$.tw.

18 crossover$.tw.

19 cross over$.tw.

20 cross‐over$.tw.

21 placebo$.tw.

22 (doubl$ adj blind$).tw.

23 (singl$ adj blind$).tw.

24 assign$.tw.

25 allocat$.tw.

26 volunteer$.tw.

27 Crossover Procedure/

28 double‐blind procedure.tw.

29 Randomized Controlled Trial/

30 Single Blind Procedure/

31 or/16‐30

32 (animal/ or nonhuman/) not human/

33 31 not 32

34 15 and 33

PsycINFO via OVID

1. (child$ or adolescent$ or infant$ or juvenil$ or pediatric$ or paediatric$ or "young person$" or "young people" or youth$ or "young adult$").ab,it.

2. exp PSYCHOLOGY/

3. exp PSYCHOTHERAPY/

4. behavior therapy/

5. (psycholog$ or (behavio?r and therapy) or hypnos$ or relaxation$ or ((family or color or colour or music or play) adj therap$) or imagery or cogniti$ or psychotherap$).ab,it.

6. 2 or 3 or 4 or 5

7. (pain$ or headache$ or "head ache$" or head‐ache$ or migraine$ or cephalalgi$ or "stomach ache$" or "tummy ache$" or "abdominal ache$" or "belly ache$" or earache$ or ear‐ache$ or toothache$ or tooth‐ache$ or odontalgi$ or dysmenorrh$ or neuralgi$).ab,it.

8. exp Pain/

9. Headache/

10. Migraine Headache/

11. Muscle Contraction Headache/

12. 7 or 8 or 9 or 10 or 11

13. 1 and 6 and 12

14 clinical trials/

15 (randomis* or randomiz*).tw.

16 (random$ adj3 (allocat$ or assign$)).tw.

17 ((clinic$ or control$) adj trial$).tw.

18 ((singl$ or doubl$ or trebl$ or tripl$) adj3 (blind$ or mask$)).tw.

19 (crossover$ or "cross over$").tw.

20 random sampling/

21 Experiment Controls/

22 Placebo/

23 placebo$.tw.

24 exp program evaluation/

25 treatment effectiveness evaluation/

26 ((effectiveness or evaluat$) adj3 (stud$ or research$)).tw.

27 or/14‐26

28 13 and 27

Study flow diagram.

Figuras y tablas -
Figure 1

Study flow diagram.

Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies.

Figuras y tablas -
Figure 2

Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies.

Methodological quality summary: review authors' judgements about each methodological quality item for each included study.

Figuras y tablas -
Figure 3

Methodological quality summary: review authors' judgements about each methodological quality item for each included study.

Forest plot of comparison: 1 Treatment versus control (headache) post‐treatment, outcome: 1.1 Pain.

Figuras y tablas -
Figure 4

Forest plot of comparison: 1 Treatment versus control (headache) post‐treatment, outcome: 1.1 Pain.

Forest plot of comparison: 3 Treatment versus control (mixed chronic pain conditions) post‐treatment, outcome: 3.1 Pain.

Figuras y tablas -
Figure 5

Forest plot of comparison: 3 Treatment versus control (mixed chronic pain conditions) post‐treatment, outcome: 3.1 Pain.

Comparison 1: Treatment versus control (headache) post‐treatment, Outcome 1: Pain

Figuras y tablas -
Analysis 1.1

Comparison 1: Treatment versus control (headache) post‐treatment, Outcome 1: Pain

Comparison 1: Treatment versus control (headache) post‐treatment, Outcome 2: Disability

Figuras y tablas -
Analysis 1.2

Comparison 1: Treatment versus control (headache) post‐treatment, Outcome 2: Disability

Comparison 1: Treatment versus control (headache) post‐treatment, Outcome 3: Depression

Figuras y tablas -
Analysis 1.3

Comparison 1: Treatment versus control (headache) post‐treatment, Outcome 3: Depression

Comparison 1: Treatment versus control (headache) post‐treatment, Outcome 4: Anxiety

Figuras y tablas -
Analysis 1.4

Comparison 1: Treatment versus control (headache) post‐treatment, Outcome 4: Anxiety

Comparison 2: Treatment versus control (headache) follow‐up, Outcome 1: Pain

Figuras y tablas -
Analysis 2.1

Comparison 2: Treatment versus control (headache) follow‐up, Outcome 1: Pain

Comparison 2: Treatment versus control (headache) follow‐up, Outcome 2: Disability

Figuras y tablas -
Analysis 2.2

Comparison 2: Treatment versus control (headache) follow‐up, Outcome 2: Disability

Comparison 2: Treatment versus control (headache) follow‐up, Outcome 3: Depression

Figuras y tablas -
Analysis 2.3

Comparison 2: Treatment versus control (headache) follow‐up, Outcome 3: Depression

Comparison 2: Treatment versus control (headache) follow‐up, Outcome 4: Anxiety

Figuras y tablas -
Analysis 2.4

Comparison 2: Treatment versus control (headache) follow‐up, Outcome 4: Anxiety

Comparison 3: Treatment versus control (mixed pain) post‐treatment, Outcome 1: Pain

Figuras y tablas -
Analysis 3.1

Comparison 3: Treatment versus control (mixed pain) post‐treatment, Outcome 1: Pain

Comparison 3: Treatment versus control (mixed pain) post‐treatment, Outcome 2: Disability

Figuras y tablas -
Analysis 3.2

Comparison 3: Treatment versus control (mixed pain) post‐treatment, Outcome 2: Disability

Comparison 3: Treatment versus control (mixed pain) post‐treatment, Outcome 3: Depression

Figuras y tablas -
Analysis 3.3

Comparison 3: Treatment versus control (mixed pain) post‐treatment, Outcome 3: Depression

Comparison 3: Treatment versus control (mixed pain) post‐treatment, Outcome 4: Anxiety

Figuras y tablas -
Analysis 3.4

Comparison 3: Treatment versus control (mixed pain) post‐treatment, Outcome 4: Anxiety

Comparison 4: Treatment versus control (mixed pain) follow‐up, Outcome 1: Pain

Figuras y tablas -
Analysis 4.1

Comparison 4: Treatment versus control (mixed pain) follow‐up, Outcome 1: Pain

Comparison 4: Treatment versus control (mixed pain) follow‐up, Outcome 2: Disability

Figuras y tablas -
Analysis 4.2

Comparison 4: Treatment versus control (mixed pain) follow‐up, Outcome 2: Disability

Comparison 4: Treatment versus control (mixed pain) follow‐up, Outcome 3: Depression

Figuras y tablas -
Analysis 4.3

Comparison 4: Treatment versus control (mixed pain) follow‐up, Outcome 3: Depression

Comparison 4: Treatment versus control (mixed pain) follow‐up, Outcome 4: Anxiety

Figuras y tablas -
Analysis 4.4

Comparison 4: Treatment versus control (mixed pain) follow‐up, Outcome 4: Anxiety

Summary of findings 1. Summary of findings

Psychological therapies compared with any control for children and adolescents with frequent headaches

Patient or population: Children and adolescents with chronic pain

Settings: Community and hospitals

Intervention: Psychological therapies (cognitive behavioural therapy or behavioural therapy)

Comparison: Any control (active, treatment‐as‐usual, wait‐list)

Outcomes

Probable outcome with control

Probable outcome with intervention

NNTB and/or relative effect
(95% CI)

No of Participants
(studies)

Quality of the evidence
(GRADE)

Comments

Pain: 50% reduction in headache frequency

Post‐treatment

Lower scores = fewer headaches

10 per 1000

24 per 1000

NNTB = 2.86;

RR 2.35 (1.67 to 3.30)

644 participants
(15 studies)

⊕⊝⊝⊝
very lowb,c,h

Pain: 50% reduction in headache frequency

Follow‐up (up to 12 months)

Lower scores = fewer headaches

10 per 1000

27 per 1000

NNTB = 3.16;

RR 2.73 (0.98 to 7.63)

223 participants

(5 studies)

⊕⊝⊝⊝
very lowb,c,e,f,g,h

Disability

Post‐treatment

Lower scores = lower reported disability

The mean disability in the intervention groups was 0.26 lower (95% CI ‐0.56 to 0.03)

446 participants

(6 studies)

⊕⊝⊝⊝
very lowd,f,g

Disability

Follow‐up

Lower scores = lower reported disability

The mean disability in the intervention groups was 0.37 lower (95% CI ‐0.65 to ‐0.10)

209 participants

(3 studies)

⊕⊝⊝⊝
very lowf,g

Anxiety

Post‐treatment

Lower scores = lower reported anxiety

The mean anxiety in the intervention groups was 0.11 lower (95% CI ‐0.39 to 0.17)

439 participants

(7 studies)

⊕⊝⊝⊝
very low a,d,f,h,i

Anxiety

Follow‐up

Lower scores = lower reported anxiety

The mean anxiety in the intervention groups was 0.12 lower (95% CI ‐0.46 to 0.21)

271 participants

(4 studies)

⊕⊝⊝⊝
very lowa,f,g

Depression

Post‐treatment

Lower scores = lower reported depression

The mean depression in the intervention groups was 0.08 lower (95% CI ‐0.28 to 0.11)

400 participants

(6 studies)

⊕⊝⊝⊝
very lowa,f,g

CI: Confidence interval; RR: Risk Ratio; NNTB; Number needed to treat to benefit.

GRADE Working Group grades of evidence
High‐quality: we are very confident that the true effect lies close to that of the estimate of the effect;
Moderate‐quality: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of effect, but there is a possibility that it is substantially different;
Low‐quality: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect;
Very low‐quality: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect.

a50 to 75% risk of bias ratings were unclear/high.

b> 75% of risk of bias ratings were unclear or high.

cConfidence intervals were wide.

dHeterogeneity (I2) was 46 to 65%.

eHeterogeneity (I2) was 66 to 100%.

f75 to 100% of studies eligible to be included in the analysis were not included in the analysis.

gSmall number of participants contributing to the outcome.

hAsymmetrical funnel plots suggesting publication bias.

iThere was mostly unclear/high risk of bias in the selective reporting category.

Figuras y tablas -
Summary of findings 1. Summary of findings
Summary of findings 2. Summary of findings

Psychological therapies compared with any control for children and adolescents with chronic pain conditions (mixed)

Patient or population: Children and adolescents with chronic pain

Settings: Community and hospitals

Intervention: Psychological therapies (cognitive behavioural therapy or behavioural therapy)

Comparison: Any control (active, treatment‐as‐usual, wait‐list)

Outcomes

Probable outcome with control

Probable outcome with intervention

No of Participants
(studies)

Quality of the evidence
(GRADE)

Comments

Pain

Post‐treatment

Lower scores = lower reported pain intensity

The mean pain intensity in the intervention group was 0.43 lower (95% CI ‐0.67 to ‐0.19)

1210 participants

(16 studies)

⊕⊝⊝⊝
very lowd,f

Pain

Follow‐up

Lower scores = lower reported pain intensity

The mean pain intensity in the intervention group was 0.08 lower (95% CI ‐0.30 to 0.13)

763 participants

(9 studies)

⊕⊝⊝⊝
very lowb,c,e,f

Disability

Post‐treatment

Lower scores = lower reported disability

The mean disability in the intervention group was 0.34 lower (95% CI ‐0.54 to ‐0.15)

1226 participants

(14 studies)

⊕⊕⊝⊝
lowc,f

Disability

Follow‐up

Lower scores = lower reported disability

The mean disability in the intervention group was 0.27 lower (95% CI ‐0.49 to ‐0.06)

866 participants

(9 studies)

⊕⊕⊝⊝
lowc,e

Anxiety

Post‐treatment

Lower scores = lower reported anxiety

The mean anxiety in the intervention group was 0.16 lower (95% CI ‐0.29 to ‐0.03)

883 participants

(8 studies)

⊕⊕⊝⊝
lowf

Anxiety

Follow‐up

Lower scores = lower reported anxiety

The mean anxiety in the intervention group was 0.01 lower (95% CI ‐0.20 to 0.18)

805 participants

(8 studies)

⊕⊕⊝⊝
lowb,f

Depression

Post‐treatment

Lower scores = lower reported depression

The mean disability in the intervention group was 0.05 lower (95% CI ‐0.23 to 0.12)

757 participants

(8 studies)

⊕⊝⊝⊝
verylowb,e,f

CI: Confidence interval.

GRADE Working Group grades of evidence
High‐quality: we are very confident that the true effect lies close to that of the estimate of the effect;
Moderate‐quality: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of effect, but there is a possibility that it is substantially different;
Low‐quality: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect;
Very low‐quality: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect.

a50 to 75% risk of bias ratings were unclear/high.

bConfidence intervals were wide.

cHeterogeneity (I2) was 46 to 65%.

dHeterogeneity (I2) was 66 to 100%.

e50 to 75% of studies eligible to be included in the analysis were not included in the analysis.

fAsymmetrical funnel plots suggesting publication bias.

Figuras y tablas -
Summary of findings 2. Summary of findings
Table 1. Duration of treatment and setting by condition

Headache Studies

Author

Illness

Treatment duration (hours)

Setting

Abram 2007

Headache

1.5

Clinic

Barry 1997

Headache

3

Unknown

Bussone 1998

Headache

7

Clinic

Chen 2014

Headache

Unknown

Unknown

Cottrell 2007

Headache

4 hours plus tasks

Home

Fichtel 2001

Headache

6.75

Clinic

Griffiths 1996

Headache

12

Home/clinic

Hickman 2015

Headache

2.8

Home/clinic

Hechler 2014*

Mixed

136.5 (3‐week intensive therapy)

Clinic

Kroener‐Herwig 2002

Headache

12

Clinic

Labbe 1984

Headache

6.7

Clinic

Labbe 1995

Headache

7.5

Clinic

Larsson 1987a

Headache

6.75

School

Larsson 1987b

Headache

5

School

Larsson 1990

Headache

Unknown

Home

Larsson 1996

Headache

3.3

Clinic

McGrath 1988

Headache

6

Unknown

McGrath 1992

Headache

8

Home/clinic

Osterhaus 1997

Headache

9.3

Clinic

Passchier 1990

Headache

2.5

School

Palermo 2016*

Mixed

5

Home/clinic

Powers 2013

Headache

13

Clinic

Richter 1986

Headache

9

Unknown

Sartory 1998

Headache

Unknown

Clinic

Scharff 2002

Headache

4

Clinic

Wicksell 2009*

Mixed

10

Clinic

Mixed Chronic Pain Studies

Author

Illness

Treatment duration hours)

Setting

Alfven 2007

RAP

Unknown

Clinic

Barakat 2010

SCD

6

Home

Daniel 2015

SCD

9.5

Home/clinic

Duarte 2006

RAP

3.3

Unknown

Gil 1997

SCD

0.75

Clinic

Greenley 2015

IBD

4

Home

Grob 2013

RAP

9

Clinic

Gulewitsch 2013

RAP/IBS

2

Clinic

Hechler 2014*

Mixed

136.5 (3‐week intensive therapy)

Clinic

Humphreys 2000

RAP

Unknown

Clinic

Kashikar‐Zuck 2005

Fibromyalgia

6

Clinic

Kashikar‐Zuck 2012

Fibromyalgia

7.5

Unknown

Levy 2010

RAP

4

Home/clinic

Levy 2016

IBD

3.5

Home/clinic

Levy 2017

RAP

3

Home/clinic

Palermo 2016*

Mixed

5

Home/clinic

Robins 2005

RAP

3.5

Clinic

Sanders 1994

RAP

6

Clinic

Van der Veek 2013

RAP

4.5

Clinic

Van Tilburg 2009

RAP

1.8

Home

Vlieger 2007

RAP/IBS

5

Clinic

Wahlund 2003

TMD

Unknown

Unknown

Wahlund 2015

TMD

6

Clinic

Wicksell 2009*

Mixed

10

Clinic

*Headache and mixed chronic pain studies were entered twice.
IBD: inflammatory bowel disease
IBS: irritable bowel syndrome
JIA: Juvenile idiopathic arthritis
RAP: Recurrent abdominal pain
SCD: Sickle cell disease
TMD: temporomandibular disorders

Figuras y tablas -
Table 1. Duration of treatment and setting by condition
Table 2. Scorecard of findings

Psychological treatments for children and adolescents with headache pain

Pain

Disability

Depression

Anxiety

Post‐treatment

Effect (15)

No effect (6)

No effect (6)

No effect (7)

< 20/arm

Effect (13)

No effect (2)

No effect (3)

No effect (4)

> 20/arm

Effect (2)

Effect (4)

No effect (3)

No effect (3)

Follow‐up

No effect (5)

Effect (3)

No effect (3)

No effect (4)

< 20/arm

Effect (4)

Unknown*

Unknown*

No effect (2)

> 20/arm

Unknown*

Effect (2)

No effect (2)

No effect (2)

Psychological treatments for children and adolescents with mixed pain conditions

Pain

Disability

Depression

Anxiety

Post‐treatment

Effect (16)

Effect (14)

No effect (8)

Effect (8)

< 20/arm

Effect (7)

Effect (6)

No effect (2)

Unknown*

> 20/arm

No effect (9)

Effect (8)

No effect (6)

Effect (7)

Follow‐up

No effect (9)

Effect (9)

No effect (7)

No effect (8)

< 20/arm

Effect (2)

No effect (2)

Unknown*

Unknown*

> 20/arm

No effect (7)

Effect (7)

No effect (6)

No effect (7)

Unknown (no data); Unknown* (only one study); Number in brackets denotes number of studies in analysis.

Figuras y tablas -
Table 2. Scorecard of findings
Table 3. Results of sensitivity analyses

Outcome

Sensitivity analysis

Pain, children with headache, post‐treatment

RR 2.79, 95% CI 2.01 to 3.89; participants = 325; studies = 15; I2 = 56%

N < 20

RR 2.79, 95% CI 2.01 to 3.89; participants = 325; studies = 15; I2 = 56%

N > 20

No studies could be included in the analysis

Pain, children with mixed pain conditions, post‐treatment

SMD ‐0.57, 95% CI ‐0.90 to ‐0.24; participants = 671; studies = 16; I2 = 74%

N < 20

SMD ‐0.84, 95% CI ‐1.27 to ‐0.41; participants = 221; studies = 7; I2 = 54%

N > 20

SMD ‐0.31, 95% CI ‐0.73 to 0.12; participants = 450; studies = 9; I2 = 79%

Disability, children with mixed pain conditions, post‐treatment

SMD ‐0.37, 95% CI ‐0.64 to ‐0.11; participants = 687; studies = 14; I2 = 60%

N < 20

SMD ‐0.67, 95% CI ‐1.21 to ‐0.13; participants = 184; studies = 6; I2 = 64%

N > 20

SMD ‐0.21, 95% CI ‐0.41 to ‐0.00; participants = 503; studies = 8; I2 = 25%

CI: confidence intervals
SMD: standardised mean difference

Figuras y tablas -
Table 3. Results of sensitivity analyses
Comparison 1. Treatment versus control (headache) post‐treatment

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1.1 Pain Show forest plot

15

644

Risk Ratio (M‐H, Random, 95% CI)

2.35 [1.67, 3.30]

1.1.1 N < 20

13

437

Risk Ratio (M‐H, Random, 95% CI)

2.86 [1.73, 4.72]

1.1.2 N > 20

2

207

Risk Ratio (M‐H, Random, 95% CI)

1.88 [1.36, 2.58]

1.2 Disability Show forest plot

6

446

Std. Mean Difference (IV, Random, 95% CI)

‐0.26 [‐0.56, 0.03]

1.2.1 N < 20

2

61

Std. Mean Difference (IV, Random, 95% CI)

0.04 [‐0.47, 0.54]

1.2.2 N > 20

4

385

Std. Mean Difference (IV, Random, 95% CI)

‐0.35 [‐0.69, ‐0.00]

1.3 Depression Show forest plot

6

400

Std. Mean Difference (IV, Random, 95% CI)

‐0.08 [‐0.28, 0.11]

1.3.1 N < 20

3

103

Std. Mean Difference (IV, Random, 95% CI)

‐0.16 [‐0.68, 0.35]

1.3.2 N > 20

3

297

Std. Mean Difference (IV, Random, 95% CI)

‐0.06 [‐0.29, 0.17]

1.4 Anxiety Show forest plot

7

439

Std. Mean Difference (IV, Random, 95% CI)

‐0.11 [‐0.39, 0.17]

1.4.1 N < 20

4

136

Std. Mean Difference (IV, Random, 95% CI)

0.01 [‐0.54, 0.57]

1.4.2 N > 20

3

303

Std. Mean Difference (IV, Random, 95% CI)

‐0.19 [‐0.49, 0.11]

Figuras y tablas -
Comparison 1. Treatment versus control (headache) post‐treatment
Comparison 2. Treatment versus control (headache) follow‐up

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

2.1 Pain Show forest plot

5

223

Risk Ratio (M‐H, Random, 95% CI)

2.73 [0.98, 7.63]

2.1.1 N < 20

4

99

Risk Ratio (M‐H, Random, 95% CI)

3.49 [1.31, 9.26]

2.1.2 N > 20

1

124

Risk Ratio (M‐H, Random, 95% CI)

1.25 [1.03, 1.52]

2.2 Disability Show forest plot

3

209

Std. Mean Difference (IV, Random, 95% CI)

‐0.37 [‐0.65, ‐0.10]

2.2.1 N < 20

1

24

Std. Mean Difference (IV, Random, 95% CI)

‐0.45 [‐1.27, 0.36]

2.2.2 N > 20

2

185

Std. Mean Difference (IV, Random, 95% CI)

‐0.36 [‐0.65, ‐0.07]

2.3 Depression Show forest plot

3

228

Std. Mean Difference (IV, Random, 95% CI)

‐0.05 [‐0.62, 0.52]

2.3.1 N < 20

1

24

Std. Mean Difference (IV, Random, 95% CI)

‐0.54 [‐1.36, 0.28]

2.3.2 N > 20

2

204

Std. Mean Difference (IV, Random, 95% CI)

0.11 [‐0.61, 0.83]

2.4 Anxiety Show forest plot

4

271

Std. Mean Difference (IV, Random, 95% CI)

‐0.12 [‐0.46, 0.21]

2.4.1 N < 20

2

67

Std. Mean Difference (IV, Random, 95% CI)

‐0.28 [‐1.00, 0.45]

2.4.2 N > 20

2

204

Std. Mean Difference (IV, Random, 95% CI)

‐0.04 [‐0.48, 0.41]

Figuras y tablas -
Comparison 2. Treatment versus control (headache) follow‐up
Comparison 3. Treatment versus control (mixed pain) post‐treatment

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

3.1 Pain Show forest plot

16

1210

Std. Mean Difference (IV, Random, 95% CI)

‐0.43 [‐0.67, ‐0.19]

3.1.1 N < 20

7

250

Std. Mean Difference (IV, Random, 95% CI)

‐0.83 [‐1.19, ‐0.46]

3.1.2 N > 20

9

960

Std. Mean Difference (IV, Random, 95% CI)

‐0.20 [‐0.45, 0.05]

3.2 Disability Show forest plot

14

1226

Std. Mean Difference (IV, Random, 95% CI)

‐0.34 [‐0.54, ‐0.15]

3.2.1 N < 20

6

213

Std. Mean Difference (IV, Random, 95% CI)

‐0.72 [‐1.17, ‐0.26]

3.2.2 N > 20

8

1013

Std. Mean Difference (IV, Random, 95% CI)

‐0.20 [‐0.37, ‐0.04]

3.3 Depression Show forest plot

8

757

Std. Mean Difference (IV, Random, 95% CI)

‐0.05 [‐0.23, 0.12]

3.3.1 N < 20

2

59

Std. Mean Difference (IV, Random, 95% CI)

‐0.27 [‐0.95, 0.41]

3.3.2 N > 20

6

698

Std. Mean Difference (IV, Random, 95% CI)

‐0.03 [‐0.21, 0.15]

3.4 Anxiety Show forest plot

8

957

Std. Mean Difference (IV, Random, 95% CI)

‐0.16 [‐0.29, ‐0.03]

3.4.1 N < 20

1

32

Std. Mean Difference (IV, Random, 95% CI)

0.12 [‐0.57, 0.82]

3.4.2 N > 20

7

925

Std. Mean Difference (IV, Random, 95% CI)

‐0.17 [‐0.30, ‐0.04]

Figuras y tablas -
Comparison 3. Treatment versus control (mixed pain) post‐treatment
Comparison 4. Treatment versus control (mixed pain) follow‐up

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

4.1 Pain Show forest plot

9

833

Std. Mean Difference (IV, Random, 95% CI)

‐0.08 [‐0.30, 0.13]

4.1.1 N < 20

2

53

Std. Mean Difference (IV, Random, 95% CI)

‐0.94 [‐1.75, ‐0.13]

4.1.2 N > 20

7

780

Std. Mean Difference (IV, Random, 95% CI)

‐0.00 [‐0.15, 0.14]

4.2 Disability Show forest plot

9

935

Std. Mean Difference (IV, Random, 95% CI)

‐0.27 [‐0.49, ‐0.06]

4.2.1 N < 20

2

53

Std. Mean Difference (IV, Random, 95% CI)

‐1.17 [‐2.60, 0.26]

4.2.2 N > 20

7

882

Std. Mean Difference (IV, Random, 95% CI)

‐0.20 [‐0.34, ‐0.07]

4.3 Depression Show forest plot

7

667

Std. Mean Difference (IV, Random, 95% CI)

0.09 [‐0.10, 0.28]

4.3.1 N < 20

1

24

Std. Mean Difference (IV, Random, 95% CI)

‐0.53 [‐1.35, 0.29]

4.3.2 N > 20

6

643

Std. Mean Difference (IV, Random, 95% CI)

0.12 [‐0.06, 0.30]

4.4 Anxiety Show forest plot

8

875

Std. Mean Difference (IV, Random, 95% CI)

‐0.01 [‐0.20, 0.18]

4.4.1 N < 20

1

32

Std. Mean Difference (IV, Random, 95% CI)

0.09 [‐0.60, 0.79]

4.4.2 N > 20

7

843

Std. Mean Difference (IV, Random, 95% CI)

‐0.01 [‐0.22, 0.19]

Figuras y tablas -
Comparison 4. Treatment versus control (mixed pain) follow‐up